Azotemia and Urinary Abnormalities¶
Chapter 55 | Part 2: Cardinal Manifestations and Presentation of Diseases
KEY CLINICAL POINTS¶
- Azotemia is defined as elevated serum creatinine due to reduced GFR, with causes categorized as prerenal, intrinsic renal, or postrenal.
- Urinalysis is critical for differentiating prerenal azotemia from acute tubular necrosis (ATN) using findings like RBC casts, WBC casts, and electrolyte excretion patterns.
- GFR estimation relies on creatinine-based formulas (Cockcroft-Gault, MDRD, CKD-EPI) and cystatin C, with limitations in populations with muscle mass or race-related biases.
- Proteinuria classification includes physiological (e.g., exercise), pathological (e.g., nephrotic syndrome), and glomerular vs. tubular origins.
- Polyuria may result from diabetes insipidus (central or nephrogenic) or solute diuresis due to glucose, mannitol, or urea.
1. DEFINITION & OVERVIEW¶
Azotemia refers to elevated serum creatinine due to reduced glomerular filtration rate (GFR). It is a clinical syndrome characterized by nitrogenous waste retention (urea, creatinine) and may result from prerenal, intrinsic renal, or postrenal causes. Urinary abnormalities include hematuria, proteinuria, casts, and altered urine volume (oliguria, polyuria).
Table 55-1: Initial Clinical and Laboratory Database for Defining Major Syndromes in Nephrology¶
| SYNDROME | IMPORTANT CLUES TO DIAGNOSIS | COMMON FINDINGS | CHAP(S). DISCUSSING |
|---|---|---|---|
| Acute or rapidly progressive renal failure | Anuria | Hypertension, hematuria | 321, 326, 328, 331 |
| Acute or rapidly progressive renal failure | Oliguria | Proteinuria, pyuria | |
| Acute or rapidly progressive renal failure | Documented recent decline in GFR | Casts, edema | |
| Acute nephritis | Hematuria, RBC casts | Proteinuria | 326 |
| Chronic renal failure | Azotemia for >3 months | Proteinuria, casts | 322 |
| Nephrotic syndrome | Proteinuria (>3.5 g/24 h) | Hypoalbuminemia, lipiduria | 326 |
| Asymptomatic urinary abnormalities | Hematuria | 326 | |
| Urinary tract infection/pyelonephritis | Bacteriuria (>10n cfu/mL) | Hematuria | 140 |
| SYNDROME | IMPORTANT CLUES TO DIAGNOSIS | COMMON FINDINGS | CHAP(S). DISCUSSING |
|---|---|---|---|
| Renal tubular defects | Electrolyte disorders | Hematuria | 327, 328 |
| Nephrolithiasis | Previous history of stone passage | Hematuria | 330 |
| Renal colic | Frequency, urgency | ||
| Azotemia, oliguria, anuria | Hematuria | ||
| Polyuria, nocturia, urinary retention | Pyuria | ||
| Slowing of urinary stream | Enuresis, dysuria | ||
| Large prostate, large kidneys | |||
| Flank tenderness, full bladder after voiding |
Table 55-2: Laboratory Findings in Acute Renal Failure¶
| INDEX | PRERENAL AZOTEMIA | OLIGURIC ACUTE RENAL FAILURE |
|---|---|---|
| BUN/P ratio | >20:1 | 10–15:1 |
| Urine sodium (meq/L) | <20 | >40 |
| Urine osmolality (mosmol/L) | >500 | <350 |
| Fractional excretion of sodium | <1% | >2% |
| Urine/plasma creatinine (U/P Cr) | >40 | <20 |
| Urinalysis (casts) | None or hyaline/granular | Muddy brown |
1.1 GFR and Azotemia¶
GFR is the primary metric of kidney function. Azotemia occurs when GFR falls below 60 mL/min/1.73 m². Creatinine-based formulas (Cockcroft-Gault, MDRD, CKD-EPI) estimate GFR, though cystatin C offers improved accuracy in certain populations. Plasma creatinine correlates with urine creatinine excretion but is influenced by muscle mass and race.
1.2 Urinary Abnormalities¶
Urinalysis reveals key findings: hematuria (RBCs, casts), proteinuria (>3.5 g/24 h for nephrotic syndrome), pyuria (WBCs, casts), and altered urine osmolality. Urine volume (oliguria, polyuria) and electrolyte excretion patterns help distinguish prerenal, intrinsic, and postrenal causes.
2. EPIDEMIOLOGY¶
Azotemia is common in populations with chronic kidney disease (CKD), sepsis, heart failure, and nephrotoxic drug exposure. Prerenal azotemia accounts for 40–80% of acute renal failure cases, while postrenal causes are rare (<5%). Intrinsic renal disease (e.g., ATN, glomerulonephritis) contributes to 20–30% of cases.
2.1 Risk Factors¶
Risk factors include dehydration, heart failure, sepsis, nephrotoxic drugs (NSAIDs, aminoglycosides), and obstructive uropathy. Chronic conditions like diabetes and hypertension increase susceptibility to CKD and azotemia.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
Azotemia arises from prerenal (reduced renal perfusion), intrinsic (glomerular or tubular injury), or postrenal (obstruction) causes. GFR reduction leads to nitrogenous waste retention, with prerenal azotemia characterized by low urine sodium (<20 meq/L) and high urine osmolality (>500 mosmol/L).
3.1 Prerenal Azotemia¶
Caused by decreased renal perfusion (e.g., hypovolemia, heart failure, vasodilators). GFR remains normal, but reduced renal blood flow leads to sodium and water retention. Urine sodium <20 meq/L and osmolality >500 mosmol/L.
3.2 Intrinsic Renal Disease¶
Includes acute tubular necrosis (ATN), glomerulonephritis, and interstitial nephritis. ATN results from ischemia or toxins, with low urine sodium (<20 meq/L) and osmolality <350 mosmol/L. Glomerular diseases present with hematuria, proteinuria, and RBC casts.
3.3 Postrenal Azotemia¶
Caused by urinary tract obstruction (e.g., stones, tumors). Urine output is reduced, with high urine sodium (>40 meq/L) and osmolality <350 mosmol/L. Renal ultrasound reveals hydronephrosis.
4. CLINICAL FEATURES¶
Symptoms include oliguria, edema, fatigue, and uremic symptoms (nausea, confusion). Signs include hypertension, peripheral edema, and flank pain. Laboratory findings include elevated BUN, creatinine, and abnormal urine sediment (casts, RBCs, WBCs).
4.1 Oliguria and Anuria¶
Oliguria (<400 mL/24 h) or anuria (<100 mL/24 h) indicates severe renal dysfunction. Anuria may result from obstruction, cortical necrosis, or acute tubular necrosis.
4.2 Hematuria and Pyuria¶
Hematuria (RBCs in urine) may indicate glomerular disease, infection, or stones. Pyuria (WBCs in urine) suggests infection (e.g., pyelonephritis) or interstitial nephritis.
5. DIFFERENTIAL DIAGNOSIS¶
Differential diagnoses include glomerulonephritis, interstitial nephritis, urinary tract infections, and malignancies. Conditions like diabetes mellitus, hypertension, and systemic lupus erythematosus may present with renal involvement.
5.1 Glomerular Diseases¶
Nephrotic syndrome (proteinuria >3.5 g/24 h, hypoalbuminemia), IgA nephropathy, and membranous glomerulopathy are distinguished by urine findings (casts, RBCs) and renal biopsy.
5.2 Tubular and Interstitial Diseases¶
Interstitial nephritis (WBC casts, eosinophils), acute tubular necrosis (muddy brown casts), and drug-induced nephrotoxicity (e.g., NSAIDs, aminoglycosides) require urine analysis and imaging.
6. INVESTIGATIONS & DIAGNOSIS¶
Diagnostic workup includes serum creatinine, BUN, urine analysis, renal ultrasound, and imaging (e.g., CT, MAG3 renogram). Urine protein/creatinine ratio and 24-h urine collection quantify proteinuria. GFR estimation uses creatinine-based formulas.
6.1 Laboratory Tests¶
Serum creatinine, BUN, electrolytes, and urine analysis (protein, RBCs, WBCs, casts) are essential. Urine osmolality and fractional excretion of sodium (FeNa) help differentiate prerenal vs. intrinsic causes.
6.2 Imaging¶
Renal ultrasound detects hydronephrosis, obstruction, or renal size changes. CT or MAG3 renogram identifies obstructive uropathy. Renal biopsy is reserved for glomerular diseases or interstitial nephritis.
7. MANAGEMENT & TREATMENT¶
Management depends on the cause: prerenal azotemia requires fluid resuscitation; intrinsic renal disease may need dialysis or specific therapies (e.g., corticosteroids for glomerulonephritis); postrenal causes require surgical intervention for obstruction.
7.1 Prerenal Azotemia¶
Treat underlying cause (e.g., dehydration, heart failure). Administer intravenous fluids and avoid nephrotoxic drugs. Monitor urine output and electrolytes.
7.2 Intrinsic Renal Disease¶
ATN: Supportive care, dialysis if severe. Glomerulonephritis: Immunosuppression (e.g., corticosteroids, cyclophosphamide). Interstitial nephritis: Discontinue offending agents and treat infections.
7.3 Postrenal Azotemia¶
Surgical removal of obstruction (e.g., stones, tumors). Catheterization for urinary retention. Monitor for complications like infection or renal failure.
8. PROGNOSIS & COMPLICATIONS¶
Prognosis varies by cause: prerenal azotemia is reversible with treatment, while intrinsic renal disease may progress to chronic kidney disease or end-stage renal failure. Complications include uremia, infections, electrolyte imbalances, and cardiovascular disease.
8.1 Uremic Complications¶
Symptomatic uremia (nausea, confusion) occurs when GFR <15 mL/min. Hyperkalemia, metabolic acidosis, and fluid overload may require dialysis.
8.2 Long-Term Outcomes¶
Chronic kidney disease (CKD) may develop from acute renal failure. Early intervention improves prognosis, while delayed treatment increases risk of progression to end-stage renal disease.
9. SPECIAL CONSIDERATIONS¶
Pregnancy: Prerenal azotemia is common due to renal vasoconstriction. Elderly: Increased risk of dehydration and drug toxicity. Pediatrics: Nephrotic syndrome is more common, with distinct presentations. Race: Cystatin C may improve GFR estimation in Black patients.
9.1 Pregnancy¶
Renal vasoconstriction and fluid shifts increase prerenal azotemia risk. Monitor for preeclampsia and gestational hypertension.
9.2 Pediatrics¶
Nephrotic syndrome is more prevalent in children. Hematuria may be due to infections or congenital anomalies. Avoid nephrotoxic drugs in pediatric patients.
10. KEY POINTS & CLINICAL PEARLS¶
- Use urine sodium and osmolality to differentiate prerenal vs. intrinsic azotemia. 2. Urinalysis (casts, RBCs, WBCs) is critical for diagnosing glomerular or interstitial disease. 3. Cystatin C improves GFR estimation in populations with muscle mass or race-related biases. 4. Polyuria may indicate diabetes insipidus or solute diuresis. 5. Early renal biopsy is indicated for glomerular disease or persistent hematuria.